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Host-mediated immunoinflammatory pathways activated by bacteria lead to destruction of
the periodontal connective tissues and alveolar bone. The objective of this study was to
elucidate the activation of the inflammatory processes in periodontal disease by quantitative
assessment of cytokines and periodontopathogens. Gingival crevicular fluids (GCF) and
subgingival plaque samples were collected from patients with chronic periodontitis and
gingivitis and from periodontally healthy sites. Vascular endothelial growth factor (VEGF),
monocyte chemoattractant protein-1 (MCP-1), and interleukin 8 (IL-8) in GCF were analyzed
by enzyme-linked immunosorbent assay. Periodontopathogens, including Bacteroides
forsythus, Campylobacter rectus, Porphyromonas gingivalis and Prevotella intermedia, were
analyzed by immunofluorescence and dark-field microscopy. There was significantly more
VEGF and IL-8 in chronic periodontitis and gingivitis sites than in periodontally healthy
sites. There were significant positive correlations between the concentrations and total
amounts of VEGF and IL-8 in chronic periodontitis and gingivitis sites, and between the
levels of periodontopathogens and the total amounts of VEGF, MCP-1 and IL-8. These data
indicate that inflammatory processes induced by periodontopathogens and the activation
of certain cytokines (VEGF, MCP-1, IL-8) in periodontal diseases may be relevant to host-
mediated destruction in chronic periodontitis.
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Periodontal disease is generally understood to be an
infectious disease caused by microbial challenge which,
although essential in the process, is insufficient on its
own to cause disease [1]. The microbes induce the host
immunoinflammatory response, which leads to per-
turbation of connective tissue and bone metabolism.
The combination of environmental and genetic risk
factors and a susceptible host leads to chronic perio-
dontitis characterized by inflammatory destruction of
connective tissue, loss of periodontal attachment, and
resorption of alveolar bone. Host inflammatory
mediators and pathways of tissue destruction have
been extensively investigated in recent years. Bacte-
rial metabolites and related molecules may also
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indirectly stimulate inflammatory infiltrate: monocytes
may release interleukin (IL)-1 [2], tumor necrosis factor
alpha (TNF-α) [3], prostaglandin E2 (PGE2) [4], IL-8 [5],
and matrix metalloproteinases [6] to activate processes
in endothelial and other periodontal cells. The aim of
this study was to investigate the relationship of
periodontal disease to vascular endothelial growth
factor (VEGF), monocyte chemoattractant protein-1
(MCP-1), and IL-8.
VEGF, also known as vascular permeability factor
[7] or vasculotropin, is a multifunctional mediator
that stimulates endothelial cell proliferation, secre-
tion of proteolytic enzymes, chemotaxis and migration,
all of which are necessary for angiogenesis. Angio-
genesis (the process by which new blood vessels
are produced from established vessels) contri-
butes to the severity of inflammation as a result of
the ability of new blood vessels to transport pro-
inflammatory cells to the lesion and supply nutrients
and oxygen to the inflamed tissues, thus increasing
the potential substrate for the production of cytokines,
adhesion molecules, and other factors of inflammation
[8].
MCP-1 belongs to the family of CC chemokines [9],
which have two adjacent cysteine residues. CC
chemokines are chemotactic for monocytes and a small
subset of lymphocytes. MCP-1 is one of the most
thoroughly characterized CC chemokines [10]. Its
expression has been detected in a number of different
disease states in vivo and has been implicated in
several pathologic processes, including atherosclerosis
[11,12], delayed hypersensitivity reactions [13], host
response to tumors [14], arthritis [15], gingivitis [16],
and osseous inflammation induced by bacterial
infection [17]. Injection of MCP-1 in vivo leads to the
predominant recruitment of monocytes [18]. MCP-1
expression by endothelial cells may be important in
the regulation of integrin expression in leukocytes.
MCP-1 produced by endothelial cells could diffuse
into monocytes in the capillary lumen and activate
adhesion molecules  that  faci l i tate  monocyte
attachment. Production of MCP-1 by mononuclear
phagocytes in the interstitial tissue could represent an
important amplification step. Monocyte chemotactic
activity in the crevicular fluids of adult periodontal
disease patients increases with the severity of the
disease [18], suggesting that MCP-1 may contribute to
the observed increased infiltration of monocytes into
periodontal tissue.
IL-8 is a chemoattractant cytokine produced by a
variety of tissue and blood cells with a distinct target
specificity for the neutrophil [5]. Neutrophils represent
the major inflammatory infiltrate in periodontitis [19]. In
diseases with neutrophil dysfunction, periodontal tissue
is lost very rapidly. Connective tissue constituents are
effectively degraded by neutrophil enzymes, released
upon activation. IL-8 is involved in the initiation and
progression of periodontal disease [20].
The purpose of this study was to elucidate the
activation of inflammatory processes in periodontal
disease by quantitative assessment of vascular
remodeling and proliferation-related cytokines
(VEGF), chemokines (MCP-1, IL-8), major periodonto-
pathogens (Bacteroides forsythus, Campylobacter rectus,
Porphyromonas gingivalis, Prevotella intermedia), and
routine clinical parameters.
MATERIALS AND METHODS
Patient selection
Thirty-six patients referred to the Department of
Periodontics, Chung-Ho Memorial Hospital, for the
treatment of periodontitis or gingivitis or routine oral
examination were selected. Some patients had a his-
tory of non-surgical treatment. However, none had
undergone scaling or root-planing in the past 3 months
except daily tooth brushing. Patients with compli-
cated medical histories, including diabetes, rheuma-
toid arthritis, and cardiac valvular defects, were ex-
cluded from the study. None of the subjects had taken
medications such as anti-inflammatory agents,
antibiotics, immunosuppressants, or contraceptives
that could affect their periodontal status for at least 3
months prior to the study. Six clinically healthy dental
personnel were selected for comparison. Radiographic
examination and assessment of clinical parameters,
including plaque index (PLI) [21], gingival index (GI)
[22], probing depth (PD) [23], and probing attachment
level (PAL), were performed. The selected sites were
categorized into chronic periodontitis (GI > 0, PD >
3 mm, PAL ≥ 3 mm), gingivitis (GI > 0, PD ≤ 3 mm,
PAL ≤ 2 mm), and periodontally healthy (GI = 0, PD ≤
3 mm, PAL ≤ 1 mm) sites.
Collection of GCF samples
In each patient, clinical measurements and gingival
crevicular fluid (GCF) samples were taken from the
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mesiobuccal sites of selected maxillary premolar-mo-
lar teeth (excluding those with crowns or cervical
restorations). After isolating the tooth with a cotton
rol l ,  the PLI  and GI were recorded and the
supragingival plaque was removed without touching
the gingiva [24]. The crevicular site was then gently
dried with an air syringe. GCF was collected with a
Periopaper gingival fluid collection strip (IDE
Interstate, Amityville, NY, USA) positioned in the
pocket or sulcus for 30 seconds. The amount of sample
collected was quantitated using a Periotron 6000 (Harco
Electronics Limited, Winnipeg, MB, Canada). Each
strip was then eluted in 500 µL elution media contain-
ing physiologic saline and 0.1% Tween 20. The eluate
was stored at –70°C until assayed.
Collection of subgingival plaque samples
Subgingival plaque samples were initially collected
using sterile paper points (Johnson Fine Absorbent
Point; Johnson and Johnson, Warminster, PA, USA)
extending into the pocket or sulcus for 10 seconds,
then using sterile curets [25]. The collected samples
were immediately transferred into micro test tubes
(Eppendorf AG, Hamburg, Germany) containing
1 mL of phosphate-buffered saline (PBS; pH 7.2) and
sent to the laboratory.
Microbiologic processing of plaque samples
Antisera to B. forsythus 335, C. rectus 372, P. gingivalis
381, and P. intermedia ATCC 25611 were prepared in
rabbits as described by Lai et al [26]. Subgingival
plaque samples were vortexed and homogenized, and
the sample suspension was smeared on glass slides,
air-dried, and acetone-fixed for 10 minutes, then stored
at –70°C. Fixed slides were warmed in a 40°C incuba-
tor for 10 minutes before processing. Specific rabbit
antisera diluted 1:320 were applied to the slides at
37°C for 30 minutes, and the slides were washed with
PBS,  incubated for  1  hour  with f luorescein
isothiocyanate-labeled goat-anti-rabbit immunoglobu-
lin (ICN Pharmaceuticals Inc., Aurora, OH, USA) di-
luted 1:40, then washed in PBS and blotted; cover slips
were added over 90% glycerol in PBS.
Slides were then examined using dark-field
microscopy (Olympus PIMC-35 ADS-2, ShinJuki,
Japan) to obtain total bacterial counts per high-power
field. Fluorescein-labeled cells in the same field were
then counted with appropriate filters to determine
the proportions of B. forsythus, C. rectus, P. gingivalis,
and P. intermedia. At least three high-power fields
containing a minimum of 300 cells were examined
for each antiserum. The proportion of each perio-
dontopathogen was the number of fluorescent bac-
teria divided by the total bacterial count in the same
field.
Quantitation of VEGF, MCP-1 and IL-8
Mediators associated with vascular endothelial
activation were analyzed using double antibody sand-
wich enzyme-linked immunosorbent assay (Quan-
tikine®, R&D systems, Minneapolis, MN, USA). The
concentrations of VEGF, MCP-1 and IL-8 in GCF
samples were calculated by comparing sample dilu-
tion curves with those of recombinant VEGF, MCP-1
and IL-8 standards. Total amounts of each cytokine
were obtained by multiplying concentrations and GCF
volumes [27].
Statistics
Statistical evaluation was carried out using ANOVA
and Tukey-Kramer to compare the levels  of
periodontopathogens in subgingival plaque and
of cytokines in GCF. Pearson’s correlation coefficients
were used to show the association between cytokine
variables. R-squares, usually considered as the
proport ion of  the  total  var iances  explained
by the explanatory variables, were computed for
cytokines and periodontopathogens. Furthermore,
a hierarchical stepwise regression strategy was applied
to select the important variables for disease severity
(i.e. PD and PAL). First, cytokine variables were
selected based on stepwise selection procedures with
a p value of less than 0.05. Next, the chosen important
variables along with periodontopathogen variables
were entered into another regression model for second-
run selection.
RESULTS
The 42 subjects contributed samples from 140 selected
sites divided into three categories: chronic perio-
dontitis, gingivitis, and periodontally healthy.
P. gingivalis was the predominant species in chronic
periodontitis, followed by B. forsythus, C. rectus and
P. intermedia. Summary statistics for periodonto-
pathogen levels in the subgingival plaque samples by
site are illustrated in Table 1.
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Table 2 shows the summary statistics for cytokine
concentrations in the GCF samples by site. VEGF was
detected in 74 of 96 and 26 of 44 site samples in
diseased and healthy sites, respectively. VEGF con-
centration in gingivitis sites was significantly higher
than that in periodontally healthy sites (Tukey-
Kramer). However, there were no significant differ-
ences in VEGF concentration between chronic peri-
odontitis sites and periodontally healthy sites or be-
tween chronic periodontitis sites or gingivitis sites,
although VEGF concentration was lower in chronic
periodontitis than in gingivitis sites. Significant dif-
ferences were found between the total amount of VEGF
in chronic periodontitis sites and periodontally healthy
sites, and between gingivitis sites and periodontally
healthy sites, respectively (p < 0.0001).
MCP-1 was detectable in only 37 of 96 samples
from diseased sites and was not detectable in
periodontally healthy sites. MCP-1 concentrations were
significantly higher in chronic periodontitis sites than
in gingivitis sites (p < 0.0001). There was also a
significant difference in the total amounts of MCP-1 in
chronic periodontitis sites and gingivitis sites.
IL-8 was detected in all 140 samples. There was no
difference in IL-8 concentration in any of the three
categories (ANOVA). However, the total amount of
IL-8 in chronic periodontitis sites was significantly
higher than in periodontally healthy sites (p < 0.0001).
Table 1. Summary statistics for periodontopathogen levels in subgingival plaque samples by site, expressed as
mean percentage (standard deviation)
n B. forsythus C. rectus P. gingivalis P. intermedia
AP 47 20.32 (5.05) 16.48 (4.43) 31.49 (5.05) 13.93 (4.69)
G 49 6.22 (2.51) 4.70 (2.74) 10.66 (6.78) 4.38 (2.74)
H 44 0.73 (1.22) 0.35 (0.79) 1.39 (2.24) 0.21 (0.57)
ANOVA * * * *
Tukey-Kramer post-hoc comparison
AP vs H * * * *
G vs H * * * *
AP vs G * * * *
AP = chronic periodontitis sites; G = gingivitis sites; H = periodontally healthy sites. *Statistically significant at overall α = 0.05.
Table 2. Summary statistics for cytokine levels in gingival crevicular fluids (GCF) by site, expressed as mean
values (standard deviation)
VEGF MCP-1 IL-8
GCF volume Concentration Total amount Concentration Total amount Concentration Total amount
n (µL) n (ng/mL) (pg/site) n (ng/mL) (pg/site) n (ng/mL) (pg/site)
AP 47 0.87 (0.27) 28 16.38 (18.88) 13.45 (15.31) 28 8.53 (16.82) 5.97 (11.59) 47 214.73 (215.09)  178.32 (180.41)
G 49 0.60 (0.24) 46 21.86 (25.13) 11.56 (9.79) 9 0.40 (1.22) 0.19 (0.49) 49 242.20 (225.00)  128.83 (92.37)
H 44 0.42 (0.15) 26 9.33 (9.66) 3.61 (3.96) 0 0 (0) 0 (0) 44 213.11 (168.97) 77.83 (53.73)
ANOVA * * * * * *
Tukey-Kramer post-hoc comparison
AP vs H * * * * *
G vs H * * *
AP vs G * * *
VEGF = vascular endothelial growth factor; MCP-1 = monocyte chemoattractant protein-1; IL-8 = interleukin-8; AP = chronic periodontitis
sites; G = gingivitis sites; H = periodontally healthy sites. *Statistically significant at overall α = 0.05.
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Correlations among the concentrations of VEGF,
MCP-1 and IL-8 with clinical parameters are shown in
Table 3. VEGF concentration was not correlated with any
of the clinical parameters, while the total amount of
VEGF was positively correlated with PLI, GI, PD and
PAL. MCP-1 concentration and total amount were only
positively correlated with GI. IL-8 concentration was
negatively correlated with PLI, but the total amount of
IL-8 was positively correlated with GI, PD and PAL.
A significant relationship was noted between the
concentrations of VEGF and IL-8, which can be ex-
pressed as: IL-8 concentration = 67.2232 + 8.029924 ×
VEGF concentration (r = 0.801, p < 0.0001; Figure A).
Similarly, there was a significant correlation between
the total amounts of VEGF and IL-8: total amount of
IL-8 = 23.1422 + 9.63561 × total amount of VEGF (r =
0.796, p < 0.0001; Figure B).
R-squared analysis showed that cytokines com-
bined with periodontopathogens contributed more to
PD and PAL than either cytokines or periodonto-
pathogens alone (Table 4). Stepwise regression analy-
sis revealed that the total amount of VEGF combined
with C. rectus was the most relevant combination for
PD and PAL (Table 5).
Table 3. Correlation among cytokine levels and clinical parameters (Pearson’s correlation coefficient, r)
VEGF MCP-1 IL-8
Concentration Total amount Concentration Total amount Concentration Total amount
PLI 0.096 0.291* 0.146 0.069 –0.212* 0.008
GI 0.188 0.401* 0.272* 0.202* –0.026 0.201*
PD 0.133 0.509* 0.135 0.153 –0.018 0.297*
PAL 0.130 0.502* 0.131 0.140 –0.008 0.317*
VEGF = vascular endothelial growth factor; MCP-1 = monocyte chemoattractant protein-1; IL-8 = interleukin-8; PLI = plaque index; GI =
gingival index; PD = probing depth; PAL = probing attachment level. *Statistically significant (p < 0.05). All site samples were pooled for
analysis.
Figure. Relationship between levels of interleukin-8 (IL-8) and vascular endothelial growth factor (VEGF) in 100 gingival crevicular
fluid samples. Each point represents a single site. (A) The regression line is IL-8 concentration = 67.2232 + 8.029924 × VEGF
concentration; r = 0.801, p < 0.0001. (B) The regression line is IL-8 total amount = 23.1422 + 9.63561 × VEGF total amount;
r = 0.796, p < 0.0001.
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DISCUSSION
VEGF and IL-8 were detected in a high proportion
of GCF samples from chronic periodontitis patients.
MCP-1 was detected only in some samples from chronic
periodontitis and gingivitis sites, especially severely
inflamed sites, but was not detectable in periodontally
healthy sites. VEGF concentration was significantly
higher in gingivitis sites than in healthy sites. However,
there was no significant difference in VEGF concentra-
t ion between chronic periodontit is  sites and
periodontally healthy sites.
Investigators have reported the presence of VEGF
in GCF from chronic inflammatory periodontal dis-
ease [28]. They report a higher volume of GCF and
total amount of VEGF in chronic periodontitis sites
than in periodontally healthy sites, which agrees with
our findings. VEGF is a multifunctional cytokine asso-
ciated with neovascularization and angiogenesis dur-
ing inflammation and wound healing and can be de-
tected in endothelial cells, neutrophils [29], plasma
cells, junctional epithelial cells, pocket epithelial cells,
and gingival epithelial cells. It stimulates the proli-
feration of endothelial cells and the secretion of
enzymes that degrade proteins, and induces chemo-
taxis and migration of leukocytes, all of which are
necessary for angiogenesis. PGE2 in GCF is related to
the active destruction of periodontal ligament [30].
Ben-Av et al reported that PGE2 is a potent factor in
VEGF synthesis, and VEGF synthesis induced by PGE2
and IL-1α is considered an important mechanism of
inflammatory angiogenesis [31].
The significantly positive correlation between the
levels of IL-8 and VEGF in this study may indicate that
Table 4. R-squared analysis for probing depth and probing attachment level
Clinical parameter GCF substance R2
Probing depth
Bacteria 0.6281
Cytokine 0.3361
Bacteria + cytokine 0.7077
Probing attachment level
Bacteria 0.5765
Cytokine 0.3148
Bacteria + cytokine 0.6588
GCF = gingival crevicular fluid. Classified into chronic periodontitis, gingivitis, and periodontally healthy categories. Bacteria represents the
proportion of subgingival plaque periodontopathogens. Cytokine includes the concentration (ng/mL) and total amount (pg/site) of vascular
endothelial growth factor, monocyte chemoattractant protein-1, and interleukin-8.
Table 5. Stepwise regression analysis for probing depth and probing attachment level
Variable Parameter estimate Standard error F p
Probing depth
VEGF concentration –0.0340 0.0080 24.92 0.0001
VEGF total amount 0.0885 0.0140 39.88 0.0001
C. rectus 0.1551 0.0128 147.69 0.0001
R2 = 0.6739
Probing attachment level
VEGF concentration –0.0455 0.0099 20.47 0.0001
VEGF total amount 0.1000 0.0174 32.87 0.0001
C. rectus 0.1845 0.0159 134.85 0.0001
R2 = 0.6457
VEGF = vascular endothelial growth factor.
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IL-8 also takes part in inflammatory angiogenesis.
Pearson’s correlation coefficient showed that the cor-
relation between IL-8 and VEGF was greater in gingi-
vitis sites than in chronic periodontitis sites, indicat-
ing that inflammatory angiogenesis may be more ac-
tive in the early stages of inflammation. The total
amount of VEGF was positively correlated with all the
tested periodontopathogens. This implied that
periodontopathogens may induce the secretion of
VEGF by interaction with neutrophils, endothelial
cells and other epithelial cells within gingival tissues
during microbial challenge, thus promoting inflam-
mation and neovascularization. Hanatani et al re-
ported that in adult periodontitis patients, the concen-
tration of VEGF in GCF was higher than that in blood,
indicating that VEGF is synthesized locally in the
periodontal tissues [32]. Johnson et al also reported
that VEGF might be the etiologic factor for gingivitis
and its progression to periodontitis by initiating the
expansion of the vascular network [33]. Future
investigations into the expression of VEGF receptors
within periodontal tissues and its relationship with
different levels of periodontal disease and health are
necessary to elucidate the biologic role of VEGF,
whether in periodontal t issue destruction or
periodontal health maintenance.
MCP-1 is chemotactic to monocytes and a small
subset of lymphocytes [10]. It can be induced directly
by bacteria and viruses and their metabolites, or indi-
rectly by external signals such as IL-1, TNF, and other
growth factors. In our study, MCP-1 was detected
only in severely inflamed gingival sites (positively
correlated with GI). This agreed with the findings of Yu
et al [34], whose report concluded that the expression of
MCP-1 was up-regulated in bacteria-associated gingivitis
sites and there was nearly no expression of MCP-1
in gingival tissues with nearly no inflammation. MCP-1
is expressed by endothelial cells and mononuclear
phagocytes in inflamed gingival tissues stimulated
by plaque bacteria [35]. MCP-1 expressed by endothelial
cells plays an important role in the regulation of leukocyte
integrins [36,37]. MCP-1 produced by activated endothe-
lial  cells may diffuse into monocytes within
the microcirculation. Activated adhesion molecules
may promote the adhesion of monocytes to the vascular
wall, resulting in diapedesis. Mononuclear phagocytes
in the interstitial tissues may stimulate the production of
MCP-1 to recruit more monocytes to promote
inflammation.
Our results showed that both the concentration
and total amount of B. forsythus were positively corre-
lated with MCP-1. Jiang et al reported that peripheral
blood mononuclear cells stimulated by P. gingivalis
could produce extensive amounts of MCP-1 and IL-8
[38]. Jiang and Graves also reported that P. gingivalis
lipopolysaccharides could stimulate bone-derived cells
such as osteoblasts to release large amounts of MCP-1
in vitro [39]. However, the in vivo bacterial biofilm is
comprised of many different bacterial communities in
microenvironments of different pH, oxygen tension
and electrical potential, and which expresses more
resistant factors against host defense mechanisms than
planktonic cultures. The implication of the positive
correlation between B. forsythus and MCP-1 is that
B. forsythus might possess a certain influence on the
production of MCP-1 by host cells in vivo. The detailed
mechanism should be investigated in future studies.
IL-8 is a member of the CXC chemokine family [9,
40], which has an intervening amino acid between the
first two cysteines. CXC chemokines are chemotactic
to neutrophils [5] and can be released from endothelial
cells, gingival fibroblasts, neutrophils, monocytes, and
phagocytes in the gingival crevice. Our previous study
reported that GCF showed dynamic changes in the
total amount of IL-8 according to the severity of perio-
dontal disease [20]. In other words, the total amount of
IL-8 in GCF from adult periodontitis sites was higher
than that from periodontally healthy sites (but the
difference in concentrations was not significant). After
phase I periodontal therapy, the total amount of IL-8
was significantly reduced. We found that IL-8 could be
detected in all samples and that there was no significant
difference in the concentration of IL-8 in chronic
periodontitis, gingivitis and periodontally healthy
sites. However, the total amount of IL-8 in chronic
periodontitis sites was significantly higher than that
in periodontally healthy sites (Tukey-Kramer post-
hoc comparison; p < 0.0001). Mathur et al found that
the mean total amount of IL-8 ±  standard deviation
was 190 ±  130 pg/site in the diseased sites of
adult periodontitis subjects, 70 ±  60 pg/site in the
healthy sites of adult periodontitis subjects, and
100 ±  100 pg/site in healthy sites of periodontally
healthy subjects [41]. Our results were slightly lower,
with total IL-8 amounts of 178 ± 180 pg/site in chronic
periodontitis sites, 129 ±  92 pg/site in gingivitis sites,
and 78 ±  54 pg/site in periodontally healthy sites,
but were eight times higher than the results in our
Cytokines in periodontal disease
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previous report [20]. We believe that this is because of
the different methods used for GCF collection. Our
previous study used an extrasulcular method to col-
lect GCF, which would not stimulate the epithelium of
the gingival crevice, and the Periopaper strip did not
have direct contact with the pocket epithelium or the
base of the gingival crevice. Mathur et al [41] and our
present study used intrasulcular methods that ex-
tended into the periodontal pocket and gingival crevice.
The total amount of IL-8 was positively correlated
with all tested periodontopathogens, among which
B. forsythus  showed a higher correlation than
P. gingivalis. Gingival epithelial cells insulted by
P. gingivalis 381 may inhibit the aggregation of IL-8,
which decreases the host periodontal defense
mechanism in local chemokine paralysis [42]. However,
this can be overcome when the bacterial biofilm is
completely established because large amounts of in-
flammatory infiltrate such as neutrophils and
lymphocytes aggregate to eliminate the microbial chal-
lenge [43].
R-squared analysis showed that cytokine and
chemokine factors combined with periodonto-
pathogens contributed more to PD and PAL than
either cytokine factors or periodontopathogens alone.
This suggests that the host response, combined with
microbial insult, has greater influence on disease
severity than either host response or microbial insult
alone. Stepwise regression analysis showed that the
total amount of VEGF and C. rectus was the most
relevant cytokine-bacteria combination for disease
severity (i.e. PD and PAL).
In conclusion,  our  data  indicate  that  the
inflammatory processes induced by periodonto-
pathogens and the activation of certain cytokines
(VEGF, MCP-1, IL-8) may be relevant to host-mediated
destruction in chronic periodontitis.
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